Treatment of hypoxic, metastatic 4T1 mouse breast tumors in an orthotopic setting with an established fluorescent sulfonamide CAIX inhibitor resulted in significant inhibition of tumor growth, whereas similar treatment of primary tumors derived from non-metastatic 67NR cells did not have an effect on tumor growth [23]. The gene discussed is CA9; the disease is neoplasm.